When was Envalior Specialty Compounds founded?

Envalior Specialty Compounds was founded on 26 Feb 1987, making it 39 years old.

Is Envalior Specialty Compounds still active?

Yes, Envalior Specialty Compounds is currently active.

What does Envalior Specialty Compounds do?

Envalior Specialty Compounds's registered main activities are Manufacture of plastics in primary forms and Manufacture of other plastic products.

Where is Envalior Specialty Compounds registered?

Envalior Specialty Compounds's registered address is Paniswijerstraat 92, 3600 Genk, Belgium.

How many employees does Envalior Specialty Compounds have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), Envalior Specialty Compounds reported 179.1 full-time equivalent employees.

What is Envalior Specialty Compounds's annual turnover?

Envalior Specialty Compounds's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €34,798,531.

Did Envalior Specialty Compounds make a profit or a loss?

Envalior Specialty Compounds's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €1,693,357.

When did Envalior Specialty Compounds last file annual accounts?

Envalior Specialty Compounds's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is Envalior Specialty Compounds B Corp certified?

We have no B Corp certification on file for Envalior Specialty Compounds.

Does Envalior Specialty Compounds hold Fairtrade certification?

No, Envalior Specialty Compounds does not currently hold Fairtrade certification.

Envalior Specialty Compounds

BE 0430.597.648

Copied!

NV/SA

Status

Active

Founded

26 Feb 1987

Size

Medium · 179.1 FTE

Age

39 yrs

Main activity

Manufacture of plastics in primary forms

Website

envalior.com

Activities

2 activities

Manufacture of plastics in primary formsManufacture of other plastic products

Financials

Turnover2025

€34.8M-1.3%

Profit / Loss2025

€1.7M+12.5%

Equity2025

€49M+3.6%

2025	2024	2023	2022
€34,798,531-1.3%	€35,254,221-35.5%	€54,700,154+36.2%	€40,170,938
€1,693,357+12.5%	€1,505,605-43.3%	€2,655,949+15.4%	€2,301,521
€48,970,166+3.6%	€47,276,809+3.3%	€45,771,204+6.2%	€43,115,254
€13,461,701-12.3%	€15,346,127+57.1%	€9,765,854-37.9%	€15,733,487
179.1-5.5%	189.6-0.1%	189.8-6.1%	202.2
€194,297+4.5%	€185,940-35.5%	€288,199+45.1%	€198,669

Frequently asked questions

01What is Envalior Specialty Compounds's official registered name?

Envalior Specialty Compounds.

02What is Envalior Specialty Compounds's enterprise number (VAT number)?

BE 0430.597.648.

03What is Envalior Specialty Compounds's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€34,798,531-1.3%	€35,254,221-35.5%	€54,700,154+36.2%	€40,170,938
	€22,154,611+7%	€20,710,880-13.5%	€23,951,490+6.6%	€22,469,411
	€1,244,488-44.4%	€2,238,682-43.2%	€3,939,049+24.9%	€3,153,000
	€4,753,802-18%	€5,795,632-22%	€7,427,778+11.3%	€6,675,897
	€5,177,592-2.8%	€5,324,706-74.5%	€20,881,842+263.2%	€5,749,762
	€1,693,357+12.5%	€1,505,605-43.3%	€2,655,949+15.4%	€2,301,521
	€345,395-29.9%	€492,782-47.3%	€935,134+59.3%	€587,088
Profitability
	13.7%-16.9%	16.4%+21.1%	13.6%-18.3%	16.6%
	4.9%+13.9%	4.3%-12%	4.9%-15.2%	5.7%
	3.5%+8.6%	3.2%-45.1%	5.8%+8.7%	5.3%
	2.2%+12.8%	1.9%-48.7%	3.8%-3.4%	3.9%
Solvency
	€77,382,314-0.3%	€77,598,461+10.4%	€70,277,606+19.4%	€58,852,125
	€34,881,482-0.4%	€35,019,814-1.6%	€35,600,032-1.1%	€35,980,074
	€48,970,166+3.6%	€47,276,809+3.3%	€45,771,204+6.2%	€43,115,254
	63.3%+3.9%	60.9%-6.5%	65.1%-11.1%	73.3%
	€13,461,701-12.3%	€15,346,127+57.1%	€9,765,854-37.9%	€15,733,487
	0.27-15.3%	0.32+52.1%	0.21-41.5%	0.36
	—	4.46-80.7%	23.11-60.5%	58.53
Liquidity
	€4,690,128+6.6%	€4,399,082+5.6%	€4,165,152+9.5%	€3,805,253
	€5,156,199-56%	€11,715,587-41.2%	€19,915,174+211.2%	€6,400,070
	€7,698,212+83.2%	€4,202,006-1.4%	€4,262,428-63.3%	€11,626,192
	€13,461,701-10.6%	€15,053,614+54.2%	€9,765,854-37.9%	€15,733,487
	3.15+13.8%	2.77-21.3%	3.52+146.6%	1.43
	€29,004,501+6.6%	€27,197,890+10.4%	€24,644,881+265.4%	€6,745,355
Efficiency
	54 days-55.4%	121 days-8.7%	133 days+128.5%	58 days
	265 days+78.6%	148 days+11.3%	133 days-49.8%	265 days
	2191 days+57.5%	1391 days-12.8%	1595 days+72.1%	927 days
	0.17-37%	0.27+12.5%	0.24-40%	0.40
Profit appropriation
	€3,315,5130%	€3,315,5130%	€3,315,5130%	€3,315,513
	€13,923,652+13.9%	€12,230,295+14%	€10,724,691+32.9%	€8,068,741

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€34,798,531-1.3%	€35,254,221-35.5%	€54,700,154+36.2%	€40,170,938
	€22,154,611+7%	€20,710,880-13.5%	€23,951,490+6.6%	€22,469,411
	€1,244,488-44.4%	€2,238,682-43.2%	€3,939,049+24.9%	€3,153,000
	€4,753,802-18%	€5,795,632-22%	€7,427,778+11.3%	€6,675,897
	€5,177,592-2.8%	€5,324,706-74.5%	€20,881,842+263.2%	€5,749,762
	€1,693,357+12.5%	€1,505,605-43.3%	€2,655,949+15.4%	€2,301,521
	€345,395-29.9%	€492,782-47.3%	€935,134+59.3%	€587,088
Profitability
	13.7%-16.9%	16.4%+21.1%	13.6%-18.3%	16.6%
	4.9%+13.9%	4.3%-12%	4.9%-15.2%	5.7%
	3.5%+8.6%	3.2%-45.1%	5.8%+8.7%	5.3%
	2.2%+12.8%	1.9%-48.7%	3.8%-3.4%	3.9%
Solvency
	€77,382,314-0.3%	€77,598,461+10.4%	€70,277,606+19.4%	€58,852,125
	€34,881,482-0.4%	€35,019,814-1.6%	€35,600,032-1.1%	€35,980,074
	€48,970,166+3.6%	€47,276,809+3.3%	€45,771,204+6.2%	€43,115,254
	63.3%+3.9%	60.9%-6.5%	65.1%-11.1%	73.3%
	€13,461,701-12.3%	€15,346,127+57.1%	€9,765,854-37.9%	€15,733,487
	0.27-15.3%	0.32+52.1%	0.21-41.5%	0.36
	—	4.46-80.7%	23.11-60.5%	58.53
Liquidity
	€4,690,128+6.6%	€4,399,082+5.6%	€4,165,152+9.5%	€3,805,253
	€5,156,199-56%	€11,715,587-41.2%	€19,915,174+211.2%	€6,400,070
	€7,698,212+83.2%	€4,202,006-1.4%	€4,262,428-63.3%	€11,626,192
	€13,461,701-10.6%	€15,053,614+54.2%	€9,765,854-37.9%	€15,733,487
	3.15+13.8%	2.77-21.3%	3.52+146.6%	1.43
	€29,004,501+6.6%	€27,197,890+10.4%	€24,644,881+265.4%	€6,745,355
Efficiency
	54 days-55.4%	121 days-8.7%	133 days+128.5%	58 days
	265 days+78.6%	148 days+11.3%	133 days-49.8%	265 days
	2191 days+57.5%	1391 days-12.8%	1595 days+72.1%	927 days
	0.17-37%	0.27+12.5%	0.24-40%	0.40
Profit appropriation
	€3,315,5130%	€3,315,5130%	€3,315,5130%	€3,315,513
	€13,923,652+13.9%	€12,230,295+14%	€10,724,691+32.9%	€8,068,741

2025

2024

2023

2022

Income statement

€34,798,531-1.3%

€35,254,221-35.5%

€54,700,154+36.2%

€40,170,938

€22,154,611+7%

€20,710,880-13.5%

€23,951,490+6.6%

€22,469,411

€1,244,488-44.4%

€2,238,682-43.2%

€3,939,049+24.9%

€3,153,000

€4,753,802-18%

€5,795,632-22%

€7,427,778+11.3%

€6,675,897

€5,177,592-2.8%

€5,324,706-74.5%

€20,881,842+263.2%

€5,749,762

€1,693,357+12.5%

€1,505,605-43.3%

€2,655,949+15.4%

€2,301,521

€345,395-29.9%

€492,782-47.3%

€935,134+59.3%

€587,088

Profitability

13.7%-16.9%

16.4%+21.1%

13.6%-18.3%

16.6%

4.9%+13.9%

4.3%-12%

4.9%-15.2%

5.7%

3.5%+8.6%

3.2%-45.1%

5.8%+8.7%

5.3%

2.2%+12.8%

1.9%-48.7%

3.8%-3.4%

3.9%

Solvency

€77,382,314-0.3%

€77,598,461+10.4%

€70,277,606+19.4%

€58,852,125

€34,881,482-0.4%

€35,019,814-1.6%

€35,600,032-1.1%

€35,980,074

€48,970,166+3.6%

€47,276,809+3.3%

€45,771,204+6.2%

€43,115,254

63.3%+3.9%

60.9%-6.5%

65.1%-11.1%

73.3%

€13,461,701-12.3%

€15,346,127+57.1%

€9,765,854-37.9%

€15,733,487

0.27-15.3%

0.32+52.1%

0.21-41.5%

0.36

—

4.46-80.7%

23.11-60.5%

58.53

Liquidity

€4,690,128+6.6%

€4,399,082+5.6%

€4,165,152+9.5%

€3,805,253

€5,156,199-56%

€11,715,587-41.2%

€19,915,174+211.2%

€6,400,070

€7,698,212+83.2%

€4,202,006-1.4%

€4,262,428-63.3%

€11,626,192

€13,461,701-10.6%

€15,053,614+54.2%

€9,765,854-37.9%

€15,733,487

3.15+13.8%

2.77-21.3%

3.52+146.6%

1.43

€29,004,501+6.6%

€27,197,890+10.4%

€24,644,881+265.4%

€6,745,355

Efficiency

54 days-55.4%

121 days-8.7%

133 days+128.5%

58 days

265 days+78.6%

148 days+11.3%

133 days-49.8%

265 days

2191 days+57.5%

1391 days-12.8%

1595 days+72.1%

927 days

0.17-37%

0.27+12.5%

0.24-40%

0.40

Profit appropriation

€3,315,5130%

€3,315,513

€13,923,652+13.9%

€12,230,295+14%

€10,724,691+32.9%

€8,068,741

Envalior Specialty Compounds

Activities

Financials

Frequently asked questions

All locations

All locations